Palliative and End of Life Care

Summary of NICE guidance for Motor neurone disease (MND)

13 November 2020Since this edition of NICE Bites was published, NICE has added a link to new MHRA safety advice on prescribing gabapentin. Please go to NICE…

Summary of NICE guidance for Care of dying adults in the last days of life

13 November 2020This edition of NICE Bites reflects current NICE guidance (as at November 2020). Please go to NICE to check for any recent updates to this…

Summary of NICE guidance for Opioids in adult palliative care

4 November 2020Since this edition of NICE Bites was published, NICE has updated changed its advice on transdermal patches to: “Use a recognised opioid dose conversion guide…

Summary of COVID-19 medicines guidance: Palliative and End of Life Care

23 October 2020This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and palliative and end of…

Patient Group Direction use in End of Life Care

10 August 2020Questions are frequently asked around the use of Patient Group Direction (PGDs) use in End of Life Care (EoLC). As with any other patient pathway…

MUS Webinar – Helping people to manage end-of-life medications at home

10 June 2020Helping people to manage end-of-life medications at home Wednesday 10 June 2020 Presented by: Ben Bowers, PhD Student and Queen’s Nurse, Department of Public Health…

Care Homes and COVID-19: Palliative and End of Life Care

17 May 2020Click here to view our most up to date Summary of COVID-19 medicines guidance: Palliative and End of Life Care. The summary page signposts to…

What naloxone doses should be used in adults to urgently reverse the effects of opioids?

19 December 2019The opioid antagonist, naloxone, is a highly effective antidote the use of which is potentially life-saving. The drug has a role in a wide range…

What are the equivalent doses of oral morphine to other oral opioids when used as analgesics in adult palliative care?

1 August 2018Morphine is generally the strong opioid of choice for treating moderate to severe cancer pain and a common question is how to convert a dose…

ARCHIVED NPSA Signal – Pain relief in terminal care in the community – November 2009

27 November 2009Key risks emerging from the review of serious incidents reported by the NHS to its National Reporting and Learning System (NRLS) were shared in in…